Winning in their blood
Image is not available
in their joints
Slide 1 - copy
previous arrow
next arrow
Polyglycan Family XL

自2006年以来，美国执照兽医用量超过100万剂。

  • "In the treatment efficacy portion, joints of Polyglycan® treated horses had fewer microscopic articular cartilage abnormalities as well.

    There has apparently been no report of any clinical or radiographic consequences in this location with clinical use in the horse.”

    C. Wayne McIlwraith, BVSc, PhD, DACVS, DACVSMR
    Orthopaedic Research Center, CSU

    David D. Frisbie, PhD, DACVS, DACVSMR
    Orthopaedic Research Center, CSU

    Excerpts from a summary document prepared by the Co-Principal Investigators of a CSU study in response to concerns raised from their paper that the use of intravenous administration of Polyglycan® might cause harm.

back to top